Join the Contact Dermatitis group to help and get support from people like you.
Contact Dermatitis News (Page 2)
Related terms: Allergic Dermatitis, Dermatitis, Allergic, Dermatitis, Contact
Childhood Obesity Tied to Pediatric Immune-Mediated Skin Diseases
TUESDAY, Aug. 27, 2024 – Early childhood obesity may increase the risk for pediatric immune-mediated skin diseases, according to a study published online Aug. 21 in the Journal of Investigative ...
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With Eczema
MONDAY, Aug. 12, 2024 – For patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a...
Gen Z Perceives Atopic Dermatitis to Be More Severe
TUESDAY, July 30, 2024 – Generation Z (Gen Z) patients present with a higher subjective perception of atopic dermatitis severity than millennial generation patients, according to a study published...
Atopic Dermatitis Has Large Impact on Sexual Function Among Women
MONDAY, July 29, 2024 – Most women with atopic dermatitis have impairment in sexual function, and about half consider that atopic dermatitis may influence their reproductive desire, according to a...
Atopic Dermatitis Has Large Impact on Sexual Function Among Women
MONDAY, July 29, 2024 – Most women with atopic dermatitis have impairment in sexual function, and about half consider that atopic dermatitis may influence their reproductive desire, according to a...
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema
WEDNESDAY, July 24, 2024 – Use of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July...
FDA Approves Zoryve for Atopic Dermatitis
THURSDAY, July 11, 2024 – The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric...
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
TUESDAY, June 18, 2024 – Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study...
High-Salt Diets Might Raise Eczema Risk
WEDNESDAY, June 5, 2024 – Doctors already warn folks off salt due to its heart risks, but new research suggests sodium isn't helping your skin either. Researchers found that as daily salt intake...
Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis
TUESDAY, May 28, 2024 – Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA...
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk
WEDNESDAY, May 8, 2024 – Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published...
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
TUESDAY, April 30, 2024 – Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases,...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...
Further information
Related condition support groups
Related drug support groups
prednisone, methylprednisolone, clobetasol, Dupixent, fluocinonide, dexamethasone, desonide, dupilumab, halobetasol